NEW YORK (GenomeWeb) – Metamark Genetics announced that three Medicare contractors have issued draft local coverage determinations (LCDs) for its ProMark prognostic test for early-stage prostate cancer.

Palmetto GBA, Noridian Healthcare Solutions, and CGS Administrators have all issued draft LCDs proposing reimbursement for the proteomic test.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.